Anavex Life Sciences Corp (AVXL)

[XenaLives]

Compiled: PRESS AND THIRD PARTY COVERAGE: 09/29/19
______________________________________________________________________________________


"Additionally, after seven weeks of treatment, blood levels of the neurotransmitter glutamate decreased significantly, while levels of another neurotransmitter, GABA, or gamma-aminobutyric acid, increased significantly. A neurotransmitter is a chemical molecule that allows nerve cells to communicate. In Rett syndrome, there tend to be abnormally high glutamate levels and abnormally low GABA levels. As such, these results suggest a “balancing” of neurotransmitter levels."
https://rettsyndromenews.com/2019/09/19/preliminary-trial-data-anavex-2-73-rett-syndrome-suggest-safety-efficacy/

Mayo Clinic researcher states that the P2a improved cognition and function:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149549864

S&P Global Market Intelligence, quoting Dr. Missling:
Failures in Alzheimer's research spur new approaches to drug development
Discussion follows:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=149043113

Experimental pill shows promising results for Parkinson's
https://pressfrom.info/au/lifestyle/health/-121247-experimental-pill-shows-promising-results-for-parkinson-s.html

NEWS!!! March 4, 2019 Third party paper on cellular recycling.
https://www.anavex.com/anavex-life-sciences-reports-publication-of-new-data-that-show-anavex2-73-induces-cellular-recycling-process-linked-to-the-prevention-and-treatment-of-age-associated-diseases/

access to above paper
https://www.mdpi.com/2073-4409/8/3/211/htm

What is proteostasis?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147258047

This MOA applies to the aging process in general:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147257995

There is a complete section on autophagy in the MOA and Medical compiled post

Anavex 2-73 and a Nobel Prize winner (from georgejjl)

Richard Engel on his son with Rett Syndrome:
https://www.today.com/parents/rett-syndrome-richard-engel-son-henry-s-milestone-life-special-t150348
A January 2018 article by Engel talks about how his son's genes are being used for research
https://www.today.com/parents/rett-syndrome-richard-engel-shares-his-son-s-rare-condition-t121886

Videos of Australian Patients from the P2a trial

Pauline Stevens the Pianist.
https://www.geelongadvertiser.com.au/news/steve-macfarlane-explains-the-alzheimers-worldfirst-drug-trial-at-caulfield-hospital/video/03fe27ae89bdce4912cabf865a99ed80

Extended P2a participant regains driver's license:
https://www.australianageingagenda.com.au/2018/07/13/next-stage-of-national-drug-trial-underway/

Thanks to polarbear for this link.. all I can say is "It's about time"...
https://alzheimersnewstoday.com/2018/10/31/anavex-2-73-slows-cognitive-decline-alzheimers-extension-study/

CA governor's task force
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146900633

Press coverage of AVXL at 2018 CTAD:
http://cnafinance.com/anavex-life-sciences-avxl-stock-gaining-on-clinical-data/20696
http://www.bioworld.com/content/tiny-anavex-thinks-big-three-year-ad-data-ctad

Recent press coverage of the 2-73 Alzheimer's trial in Australia per TTTav66:
https://www.9news.com.au/2018/10/19/18/29/dementia-pill-clinical-trial-anavex-2-73

Australian press covering the 2-73 trial:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143772297
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143773822

Apologies and thanks to the poster who first posted this article, having trouble keeping up with the good news:
https://www.yourlifechoices.com.au/health/news/alzheimers-trial-delivers-results

When the hugs and kisses stopped...
https://www.abc.net.au/news/2018-11-14/dementia-onset-when-the-hugs-stopped/10433574

UK press covering the 2-73 trial (repeat of AU coverage):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143772909